|
Oct 2
|
Eliem Therapeutics Changes Name to Climb Bio
|
|
Oct 2
|
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
|
|
Sep 28
|
Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m
|
|
Aug 26
|
Eliem Therapeutics Announces Additions to its Leadership Team
|
|
Jul 24
|
Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells Shares
|
|
Mar 6
|
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
|